FIRST HORIZON CORP (FHN)

US3205171057 - Common Stock

19.94  +0.67 (+3.48%)

After market: 19.94 0 (0%)

Fundamental Rating

3

Taking everything into account, FHN scores 3 out of 10 in our fundamental rating. FHN was compared to 406 industry peers in the Banks industry. FHN has a bad profitability rating. Also its financial health evaluation is rather negative. FHN has a decent growth rate and is not valued too expensively.



3

1. Profitability

1.1 Basic Checks

FHN had positive earnings in the past year.
In the past year FHN had a positive cash flow from operations.
Each year in the past 5 years FHN has been profitable.
Each year in the past 5 years FHN had a positive operating cash flow.

1.2 Ratios

FHN has a better Return On Assets (0.92%) than 62.87% of its industry peers.
Looking at the Return On Equity, with a value of 8.39%, FHN is in line with its industry, outperforming 53.71% of the companies in the same industry.
Industry RankSector Rank
ROA 0.92%
ROE 8.39%
ROIC N/A
ROA(3y)1.08%
ROA(5y)1.04%
ROE(3y)10.62%
ROE(5y)10.24%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

FHN has a Profit Margin of 23.22%. This is comparable to the rest of the industry: FHN outperforms 55.94% of its industry peers.
FHN's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for FHN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-1.44%
PM growth 5Y-2.09%
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

FHN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FHN has more shares outstanding
Compared to 5 years ago, FHN has more shares outstanding
Compared to 1 year ago, FHN has an improved debt to assets ratio.

2.2 Solvency

The Debt to FCF ratio of FHN is 2.70, which is a good value as it means it would take FHN, 2.70 years of fcf income to pay off all of its debts.
FHN has a Debt to FCF ratio of 2.70. This is comparable to the rest of the industry: FHN outperforms 51.73% of its industry peers.
FHN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of FHN (0.42) is worse than 73.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 2.7
Altman-Z N/A
ROIC/WACCN/A
WACC14.61%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

FHN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.49%.
The Earnings Per Share has been growing slightly by 0.28% on average over the past years.
Looking at the last year, FHN shows a decrease in Revenue. The Revenue has decreased by -8.14% in the last year.
The Revenue has been growing by 12.28% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.49%
EPS 3Y10.5%
EPS 5Y0.28%
EPS Q2Q%55.56%
Revenue 1Y (TTM)-8.14%
Revenue growth 3Y3.2%
Revenue growth 5Y12.28%
Sales Q2Q%14.21%

3.2 Future

FHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
FHN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.
EPS Next Y6.04%
EPS Next 2Y5.27%
EPS Next 3Y8.79%
EPS Next 5YN/A
Revenue Next Year-2.12%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

FHN is valuated correctly with a Price/Earnings ratio of 13.75.
FHN's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.73, FHN is valued rather cheaply.
The Price/Forward Earnings ratio is 12.58, which indicates a correct valuation of FHN.
FHN's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, FHN is valued a bit cheaper.
Industry RankSector Rank
PE 13.75
Fwd PE 12.58

4.2 Price Multiples

FHN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FHN is cheaper than 85.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.55
EV/EBITDA N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.28
PEG (5Y)48.75
EPS Next 2Y5.27%
EPS Next 3Y8.79%

6

5. Dividend

5.1 Amount

FHN has a Yearly Dividend Yield of 2.93%.
Compared to an average industry Dividend Yield of 3.02, FHN has a dividend in line with its industry peers.
FHN's Dividend Yield is a higher than the S&P500 average which is at 2.24.
Industry RankSector Rank
Dividend Yield 2.93%

5.2 History

On average, the dividend of FHN grows each year by 8.34%, which is quite nice.
FHN has paid a dividend for at least 10 years, which is a reliable track record.
FHN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.34%
Div Incr Years0
Div Non Decr Years13

5.3 Sustainability

48.61% of the earnings are spent on dividend by FHN. This is a bit on the high side, but may be sustainable.
The dividend of FHN is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP48.61%
EPS Next 2Y5.27%
EPS Next 3Y8.79%

FIRST HORIZON CORP

NYSE:FHN (12/20/2024, 8:11:12 PM)

After market: 19.94 0 (0%)

19.94

+0.67 (+3.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-16 2024-10-16/bmo
Earnings (Next)01-16 2025-01-16/amc
Inst Owners81.19%
Inst Owner Change-1.29%
Ins Owners2.22%
Ins Owner Change-2.15%
Market Cap10.57B
Analysts76
Price Target20.6 (3.31%)
Short Float %1.96%
Short Ratio1.57
Dividend
Industry RankSector Rank
Dividend Yield 2.93%
Dividend Growth(5Y)8.34%
DP48.61%
Div Incr Years0
Div Non Decr Years13
Ex-Date12-13 2024-12-13 (0.15)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.62%
Min EPS beat(2)-2.8%
Max EPS beat(2)10.03%
EPS beat(4)3
Avg EPS beat(4)3.95%
Min EPS beat(4)-2.8%
Max EPS beat(4)10.03%
EPS beat(8)5
Avg EPS beat(8)2.54%
EPS beat(12)8
Avg EPS beat(12)4.15%
EPS beat(16)12
Avg EPS beat(16)11.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-0.37%
Revenue beat(4)2
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)0.52%
Revenue beat(8)4
Avg Revenue beat(8)-0.13%
Revenue beat(12)7
Avg Revenue beat(12)0.45%
Revenue beat(16)10
Avg Revenue beat(16)0.73%
PT rev (1m)5.76%
PT rev (3m)10.18%
EPS NQ rev (1m)0.4%
EPS NQ rev (3m)-5.99%
EPS NY rev (1m)0.04%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-3.76%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.12%
Valuation
Industry RankSector Rank
PE 13.75
Fwd PE 12.58
P/S 3.24
P/FCF 7.55
P/OCF 7.33
P/B 1.17
P/tB 1.44
EV/EBITDA N/A
EPS(TTM)1.45
EY7.27%
EPS(NY)1.58
Fwd EY7.95%
FCF(TTM)2.64
FCFY13.25%
OCF(TTM)2.72
OCFY13.64%
SpS6.15
BVpS17.02
TBVpS13.84
PEG (NY)2.28
PEG (5Y)48.75
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 8.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.22%
GM N/A
FCFM 42.98%
ROA(3y)1.08%
ROA(5y)1.04%
ROE(3y)10.62%
ROE(5y)10.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-1.44%
PM growth 5Y-2.09%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 2.7
Debt/EBITDA N/A
Cap/Depr 41.41%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 185.07%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC14.61%
ROIC/WACCN/A
Cap/Depr(3y)35.68%
Cap/Depr(5y)48.36%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.63%
Profit Quality(3y)159.38%
Profit Quality(5y)134.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.49%
EPS 3Y10.5%
EPS 5Y0.28%
EPS Q2Q%55.56%
EPS Next Y6.04%
EPS Next 2Y5.27%
EPS Next 3Y8.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.14%
Revenue growth 3Y3.2%
Revenue growth 5Y12.28%
Sales Q2Q%14.21%
Revenue Next Year-2.12%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.81%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.35%
FCF growth 3Y122.87%
FCF growth 5Y46.61%
OCF growth 1Y-41.36%
OCF growth 3Y96.2%
OCF growth 5Y40.85%